Can a biotech unicorn break into the record books with a $600M IPO? Stéphane Bancel has a fortune riding on the answer

Can a biotech unicorn break into the record books with a $600M IPO? Stéphane Bancel has a fortune riding on the answer

Source: 
Endpoints
snippet: 

The Moderna CEO and his crew have posted the details on their shot at the biggest biotech IPO in the industry’s history. And Bancel will have a personal fortune of more than $700 million riding on the outcome — if they can score a record success.